Journals

Faster Drug Approvals, Weaker Data? Study Raise Questions About FDA Process
Evidence-Based Oncology > February 2020
Deana Ferreri, PhD
Overall US Cancer Mortality Rate Reaches 26-Year Decline, but Obesity-Related Cancer Deaths Rise
Evidence-Based Oncology > February 2020
Matthew Gavidia
Impact of Next-Generation Sequencing Tests on Clinical Pathways for Cancer Care
Evidence-Based Oncology > February 2020
Lance Baldo, MD
Biomarker Testing Can Direct Care, but Only if Clinicians Perform the Right Tests
Evidence-Based Oncology > February 2020
Interview by Allison Inserro
Speaking of Employers: Purchasers Detail the Challenges of Getting a Handle on Oncology Care Costs
Evidence-Based Oncology > February 2020
Mary Caffrey
From the Editor-in-Chief: The End of the Beginning
Evidence-Based Oncology > February 2020
Joseph Alvarnas, MD
Clinical Pathways: A Critical Component of Success in Episodes of Care
Evidence-Based Oncology > February 2020
Lili Brillstein, MPH, and Brian Currie
Clinical Pathways: Reducing Costs and Improving Quality Across a Network
Evidence-Based Oncology > February 2020
Marcus Neubauer, MD
Lessons From the Front: Designing and Implementing Clinical Pathways by and for Clinicians
Evidence-Based Oncology > February 2020
David M. Jackman, MD; Joanna Hamilton, MA, MS; Emily Foster, MPH; Craig A. Bunnell, MD, MPH, MBA; Louis Culot, MA; Carole Tremonti, RN, MBA; Joseph O. Jacobson, MD, MSc
Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.